Musazadeh V, Alinejad H, Esfahani NK, et al
Wuttke, W., Jarry, H., Haunschild, J., Stecher, G., Schuh, M., & Seidlova-Wuttke, D
Semaglutide activates (an agonist) the GLP-1 receptor, while tirzepatide is in a new class of dual agonists: it activates (mimics) both the GLP-1 receptor and GIP receptors (Gastric inhibit polypeptide is also known as glucose-dependent insulinotropic polypeptide.) The potency of activation for tirzepatide is 5-fold more for GIPR than GLP1
Across the market as of April 2026, monthly totals commonly sit between roughly $200 and $700 or more, which is why a headline price rarely tells the whole story
Sensitivity The analytical sensitivity of the assay is 0.36 mol/L
Olivia Evans (she/her) is an editorial assistant at Womens Health